Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AP-1

AP-1 is a PROTAC targeting anaplastic lymphoma kinase (ALK) . AP-1 is composed of PROTAC target protein ligand CS-1243648 (HY-169482) (red part), E3 ligase ligand Pomalidomide (HY-10984) (blue part) and PROTAC Linker 2- (Tert-Butoxy) -2-oxoacetic acid (HY-W687662) (black part) [1].

Product Specifications

CAS Number

[3027918-96-0]

UNSPSC

12352005

Target

Anaplastic lymphoma kinase (ALK) ; PROTACs

Related Pathways

PROTAC; Protein Tyrosine Kinase/RTK

Field of Research

Cancer

Purity

97.8

Smiles

O=C1NC(C(CC1)N2C(C3=C(C2=O)C(NCC(N4CCN(CC4)C5=CC=C(C(OC)=C5)NC6=NC=C(C(NC7=C(S(=O)(C(C)C)=O)C=CC=C7)=N6)Cl)=O)=CC=C3)=O)=O

Molecular Formula

C39H40ClN9O8S

Molecular Weight

830.31

References & Citations

[1]Lidong Gong, et al. Discovery of a miniaturized PROTAC with potent activity and high selectivity. Bioorg Chem. 2023 Jul:136:106556.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rabbit anti-human nuclear receptor co-repressor 2 polyclonal Antibody
MBS712238-01 0.1 mL

Rabbit anti-human nuclear receptor co-repressor 2 polyclonal Antibody

Ask
View Details
Rabbit anti-human nuclear receptor co-repressor 2 polyclonal Antibody
MBS712238-02 5x 0.1 mL

Rabbit anti-human nuclear receptor co-repressor 2 polyclonal Antibody

Ask
View Details
Vilanterol-D4 Triphenylacetate
RM-V091228-01 10 mg

Vilanterol-D4 Triphenylacetate

Ask
View Details
Vilanterol-D4 Triphenylacetate
RM-V091228-02 25 mg

Vilanterol-D4 Triphenylacetate

Ask
View Details
Vilanterol-D4 Triphenylacetate
RM-V091228-03 50 mg

Vilanterol-D4 Triphenylacetate

Ask
View Details
Vilanterol-D4 Triphenylacetate
RM-V091228-04 100 mg

Vilanterol-D4 Triphenylacetate

Ask
View Details